1. Home
  2. Products
  3. Customized FluoroAb™
  4. CD28
  5. Anti-CD28 MAb (Clone 9)-iFluor® 450 Succinimidyl Ester

Anti-CD28 MAb (Clone 9)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7784)

This product is comprised of an Chimeric Anti-CD28 scFv-lambda-heavy (Clone 9) labeled with iFluor® 450 Succinimidyl Ester. iFluor® 450 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.

  • TARGET
  • ANTIBODY
  • DYE
  • Name
  • CD28
  • Overview
  • Chimeric Anti-CD28 scFv-lambda-heavy (Clone 9)
  • Species Reactivity
  • Human
  • Name
  • iFluor® 450 Succinimidyl Ester
  • Color
  • Green
  • Excitation⁄Emission (nm)
  • 451/502
  • Detection method
  • Fluorescent

For Research Use Only. NOT FOR CLINICAL USE.

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

Customer Reviews and FAQs

There are currently no Customer reviews or questions for WJY0-LS7784. Click the button above to contact us or submit your feedback about this product.

Quick Links

Other Products

Same Target
CAT# Product Name Linker Payload
ADC-W-2276 Anti-CD28 (lumretuzumab)-SMCC-DM1 ADC SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
ADC-W-2331 Anti-CD28 (lulizumab pegol)-SPDB-DM4 ADC SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
ADC-W-2330 Anti-CD28 (lulizumab pegol)-SMCC-DM1 ADC SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
ADC-W-2279 Anti-CD28 (lumretuzumab)-MC-Vc-PAB-MMAE ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE
ADC-W-2278 Anti-CD28 (lumretuzumab)-MC-MMAF ADC MC (maleimidocaproyl) MMAF

Online Inquiry

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.